NASDAQ : XCUR
Exicure, Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 0.9348 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 6.12M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 6.55M |
| Enterprise Value | 4.83M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 6.55M |
| Shares Outstanding | 6.55M |
| Shares Change (YoY) | +47.91% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 7.46% |
| Owned by Institutions (%) | 2.17% |
| Float | 3.10M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 6.59 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.56 |
| Quick Ratio | 0.41 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7,309.00 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -168.37% |
| Return on Assets (ROA) | -30.32% |
| Return on Invested Capital (ROIC) | -88.56% |
| Return on Capital Employed (ROCE) | -101.13% |
| Weighted Average Cost of Capital (WACC) | 24.24% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$8.28M |
| Employee Count | 1 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | -634,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 3.64 |
| 52-Week Price Change | -77.35% |
| 50-Day Moving Average | 1.19 |
| 200-Day Moving Average | 2.72 |
| Relative Strength Index (RSI) | 43.17 |
| Average Volume (20 Days) | 65,110 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 42,892 |
| Short Previous Month | 37,561 |
| Short % of Shares Out | 0.66% |
| Short % of Float | 1.39% |
| Short Ratio (days to cover) | 1.42 |
Incomestatement
| Measure | Value |
|---|
| Revenue | n/a |
| Gross Profit | 1.26M |
| Operating Income | -7.31M |
| Pretax Income | -8.92M |
| Net Income | -8.28M |
| EBITDA | -7.11M |
| EBIT | -7.31M |
| Earnings Per Share (EPS) | -$1.30 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 1.72M |
| Total Debt | n/a |
| Net Cash | 1.72M |
| Net Cash Per Share | $0.26 |
| Equity (Book Value) | 977,000 |
| Book Value Per Share | 0.15 |
| Working Capital | -1.85M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -6.70M |
| Capital Expenditures | 319,000 |
| Depreciation & Amortization | 199,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -6.39M |
| FCF Per Share | -$0.98 |
Margins
| Measure | Value |
|---|
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -47.91% |
| Shareholder Yield | -47.91% |
| Earnings Yield | -130.22% |
| FCF Yield | -99.03% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Aug 28, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:5 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |